Eisele Jeffrey

EDGAR CIK 0001827326

Apellis Pharmaceuticals, Inc. - APLS

Officer
Chief Development Officer
Direct Buys
0
$0
0 Shares
Direct Sells
4
($57,149)
-1,896 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/29/2025
01/30/2025
Sell
-278 @ $29.52
($8,208) 55,312 (-0.50%) Direct
01/22/2025
01/23/2025
Sell
-1,291 @ $30.43
($39,279) 55,590 (-2.27%) Direct
01/13/2025
01/14/2025
Sell
-264 @ $28.70
($7,577) 56,881 (-0.46%) Direct
12/23/2024
12/27/2024
Sell
-63 @ $33.09
($2,085) 57,145 (-0.11%) Direct